The Graduate Program “Molecular Basis of Human Diseases” (https://mscs.uoc.gr/mbhd/) started its operation in 2023It is one of the first graduate programs offered by the Medical School and the first one in foreign language.
Based on its study regulations, an external evaluation is being made every five years by a group of Academics
from Greece and abroad.

The “4th External Evaluation” took place on Friday, October 11th 2024.
The Committee was consisted of the following members:

-Michael Czech PhD, Professor of Molecular Medicine, UMass Chan Medical School, Boston, USA
-Silvia Corvera MD PhD, Professor of Molecular Medicine, UMass Chan Medical School, Boston, USA
-Lars Rönnblom MD PhD, Professor of Rheumatology, Department of Medical Sciences, University of Uppsala,
SWEDEN
-Constantine A. Stratakis MD PhD, Professor of Pediatrics, National and Kapodistrian University of Athens
Medical School, Athens, GREECE & Senior Associate NICHD, NIH, Bethesda, MD, USA
-Iannis Talianidis PhD, Research Director, Former Director of the Institute of Molecular Biology and
Biotechnology, IMBB-FoRTH Crete, GREECE
The Committee made a critical evaluation at all levels of the program’s operations and suggested actions to be
taken for further improvements (https://mscs.uoc.gr/mbhd/wp-content/uploads/sites/11/2024/10/4th-ExternalEvaluation-Report.pdf).

The members of the Co-ordinating Committee of the Program, P. Sidiropoulos (Director), D. Kardassis, P.
Verginis, C. Tsatsanis and G. Chamilos, are grateful to the Medical School, the Departments of Biology, Materials
Science and Engineering as well as IMBB-FoRTH for their support and invaluable contributions to the quality of the Program.

Press Release